China National Medicines (SHSE:600511) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Additional Paid-In Capital?

China National Medicines's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥992 Mil) but then stayed the same from Dec. 2023 (¥992 Mil) to Mar. 2024 (¥0 Mil).

China National Medicines's annual additional paid-in capital increased from Dec. 2021 (¥992 Mil) to Dec. 2022 (¥996 Mil) but then declined from Dec. 2022 (¥996 Mil) to Dec. 2023 (¥992 Mil).

China National Medicines Additional Paid-In Capital Historical Data

The historical data trend for China National Medicines's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines Additional Paid-In Capital Chart

China National Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

991.57

14.05

991.57

996.30

991.57

China National Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															-	991.57	-	991.57	-

China National Medicines Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

China National Medicines Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of China National Medicines's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

Executives

Chen Zhang Qing

Director

China National Medicines (SHSE:600511) Headlines

No Headlines